首页> 外文期刊>Mutation Research: International Journal on Mutagenesis, Chromosome Breakage and Related Subjects >Induction of chromosome loss in Saccharomyces cerevisiae strain D61.M by selected benzimidazole compounds.
【24h】

Induction of chromosome loss in Saccharomyces cerevisiae strain D61.M by selected benzimidazole compounds.

机译:通过选定的苯并咪唑化合物诱导啤酒酵母D61.M菌株的染色体丢失。

获取原文
获取原文并翻译 | 示例
           

摘要

Twenty-two benzimidazole compounds were tested for induction of chromosome loss (CHRL) in the diploid yeast Saccharomyces cerevisiae strain D61.M. Six compounds tested positive for CHRL induction: mebendazole, albendazole, RS-9237-000, fenbendazole, 2-benzimidazolylacetonitrile, and thiabendazole. Mebendazole, albendazole, RS-9237-000, and fenbendazole were strongly positive only after modified testing media were used to enhance solubility. The compounds that tested negative for CHRL were 2-phenylbenzimidazole, 2-(2-pyridyl)benzimidazole, benzimidazole, 2-aminobenzimidazole, 2-amino-5,6-dimethylbenzimidazole, 2-(aminomethyl)benzimidazole dihydrochloride hydrate, 5,6-dimethylbenzimidazole, 2-guanidinobenzimidazole, 2-methylbenzimidazole, 2-(methylmercapto) benzimidazole, 1-methyl-2-phenylbenzimidazole, 2-benzimidazolylurea, RS-65255-000, oxibendazole, and RS-95005-000. One chemical, cambendazole, tested negative or only marginally positive. Modified testing medium was also used to enhance the solubilityof 2-phenylbenzimidazole, oxibendazole, and RS-95005-000. Because no toxicity was observed with oxibendazole or RS-95005-000, the negative results obtained with these two compounds could not be considered definitive.
机译:测试了22种苯并咪唑化合物在二倍体酵母啤酒酵母D61.M菌株中诱导染色体丢失(CHRL)。测试了六种对CHRL诱导呈阳性的化合物:甲苯达唑,阿苯达唑,RS-9237-000,芬苯达唑,2-苯并咪唑基乙腈和噻苯达唑。仅在使用改良的测试介质提高溶解度后,甲苯苯达唑,阿苯达唑,RS-9237-000和芬苯达唑才呈强阳性。 CHRL测试阴性的化合物是2-苯基苯并咪唑,2-(2-吡啶基)苯并咪唑,苯并咪唑,2-氨基苯并咪唑,2-氨基-5,6-二甲基苯并咪唑,2-(氨基甲基)苯并咪唑二盐酸盐水合物,5,6-二甲基苯并咪唑,2-胍基苯并咪唑,2-甲基苯并咪唑,2-(甲基巯基)苯并咪唑,1-甲基-2-苯基苯并咪唑,2-苯并咪唑基脲,RS-65255-000,奥昔达唑和RS-95005-000。一种化学品,康苯达唑,测试阴性或仅略微阳性。改良的测试介质还用于增强2-苯基苯并咪唑,奥昔达唑和RS-95005-000的溶解度。由于未观察到奥昔达唑或RS-95005-000的毒性,因此不能认为用这两种化合物获得的阴性结果是确定的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号